LENZ Therapeutics, Inc. (LENZ) Equity Ratio (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Equity Ratio for 2 consecutive years, with 0.26 as the latest value for Q3 2023.
- On a quarterly basis, Equity Ratio fell 127.65% to 0.26 in Q3 2023 year-over-year; TTM through Sep 2023 was 0.26, a 127.65% decrease, with the full-year FY2022 number at 0.08, changed N/A from a year prior.
- Equity Ratio was 0.26 for Q3 2023 at LENZ Therapeutics, down from 0.18 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q2 2022 to a low of 0.26 in Q3 2023.